Antagonism by physostigmine of the "running fit" caused by levorphanol, a morphine congener, in mice.
1. Drugs of the morphine type cause a stereotyped "running fit" in the mouse.2. The intensity and duration of this response are related to the dose.3. Measurement of this phenomenon serves as a good method for the quantitative comparison of drugs of this type and for the study of their antagonists.4. Intracerebral injection of physostigmine antagonized the "running fit" induced by a wide range of doses of levorphanol.5. The results are consistent with the hypothesis that drugs of the morphine type act by retarding the release of acetylcholine at some central cholinergic synapses.
D000109:Acetylcholine / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000378:metabolism; D007981:Levorphanol / Q000037:antagonists & inhibitors*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology*; D013997:Time Factors
D007981:Levorphanol; D010830:Physostigmine; D000109:Acetylcholine
J Physiol. 1965 Apr;177:411-9
14321488
J Pharmacol Exp Ther. 1951 Sep;103(1):93-105
14881072
Br J Pharmacol Chemother. 1957 Mar;12(1):115-8
13413162
Br J Pharmacol Chemother. 1957 Mar;12(1):12-5
13413144
Br J Pharmacol Chemother. 1966 May;27(1):81-92
5961471
Nature. 1952 Apr 26;169(4304):712-3
14956997
Br J Pharmacol Chemother. 1957 Mar;12(1):119-27
13413163